Ym. Kirova et al., RADIATION-INDUCED SARCOMAS FOLLOWING RADIOTHERAPY FOR BREAST-CANCER -6 CASE-REPORTS AND A REVIEW OF THE LITERATURE, Breast, 7(5), 1998, pp. 277-282
Seven patients with radiation-induced sarcomas (RIS) following radioth
erapy (RT) for breast cancer were treated between 1983 and 1994 at the
'Henri Mondor' University Hospital (France). All patients underwent s
urgery and RT for breast cancer. Only one patient received chemotherap
y (CT). All patients at the time of diagnosis of RIS were free of dise
ase. Radiation-induced sarcoma appeared with a latency period varying
from 5 years to 18 years (median, 11 years). The age of the patients r
anged from 39 years to 88 years (median, 58.1 years) at the time of di
agnosis of the sarcoma. The sarcomas occurred as follows: two in the t
reated breast, two in the chest wall, one in the preclavicular area an
d one in the axillary region. The histological types of sarcomas were:
angiosarcoma (1), fibrosarcoma (2), osteosarcoma (1), malignant fibro
us histiocytoma (MFH) (1), and highly malignant undifferentiated sarco
ma (1). All six patients received treatment for their sarcoma: all und
erwent surgery, one had combined therapy of RT and CT, two patients in
combination with CT, and one with immunotherapy also. Three patients
are still alive. Two patients who died had local recurrence and metast
atic disease. One had locally recurrent sarcoma only. Among the patien
ts wine are still alive, one has ovarian metastasis of breast cancer,
one has local recurrence of sarcoma, and one is free of disease. The o
verall survival ranges from 14 months to 91 months (median, 32.6 month
s). Radiation therapy can induce malignancies after a latent period of
several years. Radiation-induced sarcomas are associated with poor ov
erall prognosis. The treatment in most cases is late and ineffective,
and careful follow-up is needed. There are still many uncertainties an
d questions concerning RIS.